Form 4 Tracker
CORCEPT THERAPEUTICS INC
CORT

84 insider filings · Latest: Oct 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 17, 2026Jun 18 8:30 PMDavid L MahoneyDirector
Sale
20,000$84.53$1.7M26,147(I)

View →

Jun 15, 2026Jun 17 8:30 PMAtabak MokariChief Financial Officer
Sale
40,000$81.15$3.2M16,130(D)

View →

Jun 16, 2026Jun 16 7:06 PMMAHONEY DAVID L
Proposed Sale
20,000$83.34$1.7M—

View →

Jun 16, 2026Jun 16 5:55 PMWILSON JAMES N
Proposed Sale
30,000$83.20$2.5M—

View →

Jun 2, 2026Jun 4 8:49 PMWilliam GuyerChief Development Officer
Sale
20,000$70.60$1.4M3,985(D)

View →

Jun 1, 2026Jun 3 11:20 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Sale
25,000$70.21$1.8M8,977(D)

View →

Jun 1, 2026Jun 3 11:20 PMAtabak MokariChief Financial Officer
Sale
40,000$70.00$2.8M15,257(D)

View →

Jun 1, 2026Jun 2 8:05 PMBELANOFF JOSEPH KDirector, Chief Executive Officer
Sale
12,837$69.74$895.3K2,565,489(I)

View →

Jun 2, 2026Jun 2 6:25 PMGuyer William
Proposed Sale
20,000$70.44$1.4M—

View →

Jun 1, 2026Jun 1 9:50 PMMokari Atabak
Proposed Sale
160,000$70.00$11.2M—

View →

Jun 1, 2026Jun 1 3:40 PMBELANOFF JOSEPH K
Proposed Sale
12,837$69.49$892.0K—

View →

May 27, 2026May 29 10:11 PMJoseph Douglas LyonChief Accounting & Technology Officer
Sale
5,000$65.00$325.0K6,230(D)

View →

May 27, 2026May 29 10:03 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Sale
75,000$65.59$4.9M8,977(D)

View →

May 27, 2026May 27 10:07 PMMaduck Sean
Proposed Sale
150,000$65.59$9.8M—

View →

May 20, 2026May 20 4:46 PMLyon Joseph Douglas
Proposed Sale
5,000$58.22$291.1K—

View →

May 5, 2026May 7 8:30 PMWilliam GuyerChief Development Officer
Sale
20,000$51.83$1.0M2,231(D)

View →

May 1, 2026May 5 8:30 PMBELANOFF JOSEPH KDirector, Chief Executive Officer
Sale
40,000$50.10$2.0M2,878,326(I)

View →

May 5, 2026May 5 3:13 PMGuyer William
Proposed Sale
20,000$51.60$1.0M—

View →

May 1, 2026May 1 4:30 PMBELANOFF JOSEPH K
Proposed Sale
40,000$46.52$1.9M—

View →

Apr 7, 2026Apr 8 11:34 PMWilliam GuyerChief Development Officer
Sale
20,000$40.97$819.4K2,231(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Feb 27, 2026Mar 3 11:16 PMAtabak MokariChief Financial Officer
Grant/Award
140,000$35.70140,000(D)

View →

Feb 27, 2026Mar 3 11:14 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Grant/Award
140,000$35.70140,000(D)

View →

Feb 27, 2026Mar 3 11:14 PMHazel HuntChief Scientific Officer
Grant/Award
140,000$35.70140,000(D)

View →

Feb 27, 2026Mar 3 11:13 PMGary Charles RobbChief Business Officer
Grant/Award
140,000$35.70140,000(D)

View →

Feb 27, 2026Mar 3 11:13 PMWilliam GuyerChief Development Officer
Grant/Award
140,000$35.70140,000(D)

View →

Feb 24, 2026Feb 26 9:45 PMJames N WilsonDirector
Option Exercise
100,000$3.880(D)

View →

Feb 9, 2026Feb 11 10:26 PMHazel HuntChief Scientific Officer
Option Exercise
150,000$3.880(D)

View →

Feb 3, 2026Feb 5 10:42 PMWilliam GuyerChief Development Officer
Option Exercise
20,000$21.65230,000(D)

View →

Jan 27, 2026Jan 29 9:10 PMBAKER G LEONARD JRDirector
Option Exercise
140,000$15.150(D)

View →

← Previous

Page 3 of 3